ORPP logo
Image from Google Jackets

Magnetic Resonance Spectroscopy of Breast Tumors.

By: Material type: TextTextPublisher: New York : Nova Science Publishers, Incorporated, 2008Copyright date: ©2009Edition: 1st edDescription: 1 online resource (176 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781612096940
Subject(s): Genre/Form: Additional physical formats: Print version:: Magnetic Resonance Spectroscopy of Breast TumorsDDC classification:
  • 616.99/44907548
LOC classification:
  • RC280.B8 -- M2555 2009eb
Online resources:
Contents:
Intro -- MAGNETIC RESONANCE SPECTROSCOPY OF BREAST TUMORS -- MAGNETIC RESONANCE SPECTROSCOPY OF BREAST TUMORS -- Dedication -- Contents -- Preface -- Introduction -- Breast Diseases and Cancer - An Overview -- Methods of Breast Cancer Detection -- Magnetic Resonance Imaging and Breast Cancer -- Basic Principle of 1H MRS -- 1H MRS in Diagnostic Radiology -- 1H MRS in Breast Cancer -- 1H MRS in Axillary Lymph Nodes -- 1H MRS in Monitoring Disease Progress -- In Vitro 1H MRS -- References -- Basic Principles and Techniques of MR Spectroscopy -- 2.1. Introduction -- 2.2. Physical Basis for Clinical MRS -- 2.2.1. Nuclear Spin -- 2.2.2. Net Magnetization -- 2.2.3. Larmor Frequency and Resonance -- 2.2.4. Chemical Shift -- 2.2.5. Scalar or J-Coupling -- 2.3. Techniques for Clinical MRS -- 2.3.1. Spatial Localization -- 2.3.2. Signal Saturation or Suppression -- References -- Basic Pathology of Breast Tumors -- 3.1. Benign Breast Tumors -- 3.1.1. Fibroadenoma -- 3.1.2. Tubular Adenoma -- 3.1.3. Hamartoma -- 3.1.4. Phyllodes Tumors -- 3.2. Malignant Breast Tumors -- 3.2.1. Carcinoma in Situ (CIS) -- 3.2.2. Ductal Carcinoma in Situ (DCIS) -- 3.2.3. Paget's Disease of the Nipple -- 3.2.4. Lobular Carcinoma in Situ (LCIS) -- 3.3. Invasive Carcinoma -- 3.3.1. Invasive Ductal Carcinoma (IDC) -- 3.3.2. Tubular Carcinoma -- 3.3.3. Mucinous Carcinoma -- 3.3.4. Medullary Carcinoma -- 3.3.5. Invasive Papillary Carcinoma -- 3.3.6. Metaplastic Carcinoma -- 3.3.7. Inflammatory Carcinoma -- 3.3.8. Invasive Lobular Carcinoma (ILC) -- 3.4. Sarcomas and Other Tumors -- 3.4.1. Malignant Phyllodes Tumor -- 3.4.2. Sarcomas -- References -- Magnetic Resonance Imaging of Breast Tumors -- 4.1. Introduction -- 4.2. Overview of Typical Findings of Breast MRI -- Standardization of MRI Reporting -- Analysis of Lesion Characteristics.
4.3. Interpretation Models for Breast Lesions - Morphology vs. Dynamic MRI -- 4.4. MRI Features of Malignant Lesions -- 4.4.1. Interpretation Models Described in the Literature -- 4.4.2. Malignant Lesions: False Negatives and Positives -- 4.4.3. MR Features of Ductal Carcinoma In Situ (DCIS) -- 4.5. MRI Features of Benign Lesions -- 4.5.1. Cysts and Fibrocystic Changes -- 4.5.2. Hormonal Stimulation -- 4.5.3. Fibroadenoma and Fibroadenomatoid Changes -- 4.5.4. Benign Phyllodes Tumor -- 4.5.5. Papilloma -- 4.5.6. Hamartoma -- 4.5.7. Fat Necrosis -- 4.5.8. Radial Scar/Complex Sclerosing Lesions -- References -- In Vivo 1H Magnetic Resonance Spectroscopy of Breast Tumors -- 5.1. Introduction -- 5.2. Imaging of Breast Lesions -- 5.3. Methodology -- 5.4. Malignant Breast Lesions -- 5.4.1. Choline Metabolism -- 5.4.2. MRS of Malignant Lesions -- 5.4.3. MRS in Monitoring Response to Treatment -- 5.5. Ductal Carcinoma In Situ -- 5.6. Benign Breast Lesions and Non-Pathological Breast Tissues -- References -- Role of Magnetic Resonance Spectroscopy in Imaging of Axillary Lymph Nodes in Breast Cancer -- 6.1. Introduction -- 6.2. Ultrasonography, Color Doppler Sonography, Ultrasound-Guided Fine Needle Aspiration Biopsy (US-FNAB) -- 6.3. Preoperative Breast Cancer Staging with MR Imaging of the Axilla Using Ultrasmall Superparamagnetic Iron Oxide (USPIO) Enhancement -- 6.4. Axillary Lymph Node Staging in Breast Cancer with (Fluorine-18)-Fluoro-2-Deoxy- D-Glucose [18F] FDG-PET Scanning -- 6.5. Sentinel Lymph Node Biopsy for Breast Cancer -- 6.6. Proton MR Spectroscopy -- References -- In Vitro, Ex Vivo and HRMAS MRS of Breast Tumors -- 7.1. Introduction -- 7.2. In Vitro MRS of Breast Tumors -- 7.2.1. Sample Preparation -- 7.2.1.1. Perchloric Acid Extraction -- 7.2.1.2. Chloroform-Methanol Extraction -- 7.2.1.3. Dual Extraction -- 7.2.2. MRS Method.
7.2.3. Results -- 7.2.3.1. 1H MRS on Perchloric Acid Extract -- 7.2.3.2. 31P MRS on Perchloric Acid Extracts -- 7.2.3.3. 31P MRS on Chloroform-Methanol Extracts -- 7.2.3.4. 1H MRS Based on Dual Extraction Technique -- 7.3. Ex Vivo MRS of Breast Tumors -- 7.3.1. Sample Preparation -- 7.3.2. MRS Method -- 7.3.3. Results -- 7.4. HRMAS Spectroscopy of Breast Tumors -- 7.4.1. Sample Preparation -- 7.4.2. MRS Method -- 7.4.3. Results -- 7.5. Summary -- References -- Future Directions -- References -- Index.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Intro -- MAGNETIC RESONANCE SPECTROSCOPY OF BREAST TUMORS -- MAGNETIC RESONANCE SPECTROSCOPY OF BREAST TUMORS -- Dedication -- Contents -- Preface -- Introduction -- Breast Diseases and Cancer - An Overview -- Methods of Breast Cancer Detection -- Magnetic Resonance Imaging and Breast Cancer -- Basic Principle of 1H MRS -- 1H MRS in Diagnostic Radiology -- 1H MRS in Breast Cancer -- 1H MRS in Axillary Lymph Nodes -- 1H MRS in Monitoring Disease Progress -- In Vitro 1H MRS -- References -- Basic Principles and Techniques of MR Spectroscopy -- 2.1. Introduction -- 2.2. Physical Basis for Clinical MRS -- 2.2.1. Nuclear Spin -- 2.2.2. Net Magnetization -- 2.2.3. Larmor Frequency and Resonance -- 2.2.4. Chemical Shift -- 2.2.5. Scalar or J-Coupling -- 2.3. Techniques for Clinical MRS -- 2.3.1. Spatial Localization -- 2.3.2. Signal Saturation or Suppression -- References -- Basic Pathology of Breast Tumors -- 3.1. Benign Breast Tumors -- 3.1.1. Fibroadenoma -- 3.1.2. Tubular Adenoma -- 3.1.3. Hamartoma -- 3.1.4. Phyllodes Tumors -- 3.2. Malignant Breast Tumors -- 3.2.1. Carcinoma in Situ (CIS) -- 3.2.2. Ductal Carcinoma in Situ (DCIS) -- 3.2.3. Paget's Disease of the Nipple -- 3.2.4. Lobular Carcinoma in Situ (LCIS) -- 3.3. Invasive Carcinoma -- 3.3.1. Invasive Ductal Carcinoma (IDC) -- 3.3.2. Tubular Carcinoma -- 3.3.3. Mucinous Carcinoma -- 3.3.4. Medullary Carcinoma -- 3.3.5. Invasive Papillary Carcinoma -- 3.3.6. Metaplastic Carcinoma -- 3.3.7. Inflammatory Carcinoma -- 3.3.8. Invasive Lobular Carcinoma (ILC) -- 3.4. Sarcomas and Other Tumors -- 3.4.1. Malignant Phyllodes Tumor -- 3.4.2. Sarcomas -- References -- Magnetic Resonance Imaging of Breast Tumors -- 4.1. Introduction -- 4.2. Overview of Typical Findings of Breast MRI -- Standardization of MRI Reporting -- Analysis of Lesion Characteristics.

4.3. Interpretation Models for Breast Lesions - Morphology vs. Dynamic MRI -- 4.4. MRI Features of Malignant Lesions -- 4.4.1. Interpretation Models Described in the Literature -- 4.4.2. Malignant Lesions: False Negatives and Positives -- 4.4.3. MR Features of Ductal Carcinoma In Situ (DCIS) -- 4.5. MRI Features of Benign Lesions -- 4.5.1. Cysts and Fibrocystic Changes -- 4.5.2. Hormonal Stimulation -- 4.5.3. Fibroadenoma and Fibroadenomatoid Changes -- 4.5.4. Benign Phyllodes Tumor -- 4.5.5. Papilloma -- 4.5.6. Hamartoma -- 4.5.7. Fat Necrosis -- 4.5.8. Radial Scar/Complex Sclerosing Lesions -- References -- In Vivo 1H Magnetic Resonance Spectroscopy of Breast Tumors -- 5.1. Introduction -- 5.2. Imaging of Breast Lesions -- 5.3. Methodology -- 5.4. Malignant Breast Lesions -- 5.4.1. Choline Metabolism -- 5.4.2. MRS of Malignant Lesions -- 5.4.3. MRS in Monitoring Response to Treatment -- 5.5. Ductal Carcinoma In Situ -- 5.6. Benign Breast Lesions and Non-Pathological Breast Tissues -- References -- Role of Magnetic Resonance Spectroscopy in Imaging of Axillary Lymph Nodes in Breast Cancer -- 6.1. Introduction -- 6.2. Ultrasonography, Color Doppler Sonography, Ultrasound-Guided Fine Needle Aspiration Biopsy (US-FNAB) -- 6.3. Preoperative Breast Cancer Staging with MR Imaging of the Axilla Using Ultrasmall Superparamagnetic Iron Oxide (USPIO) Enhancement -- 6.4. Axillary Lymph Node Staging in Breast Cancer with (Fluorine-18)-Fluoro-2-Deoxy- D-Glucose [18F] FDG-PET Scanning -- 6.5. Sentinel Lymph Node Biopsy for Breast Cancer -- 6.6. Proton MR Spectroscopy -- References -- In Vitro, Ex Vivo and HRMAS MRS of Breast Tumors -- 7.1. Introduction -- 7.2. In Vitro MRS of Breast Tumors -- 7.2.1. Sample Preparation -- 7.2.1.1. Perchloric Acid Extraction -- 7.2.1.2. Chloroform-Methanol Extraction -- 7.2.1.3. Dual Extraction -- 7.2.2. MRS Method.

7.2.3. Results -- 7.2.3.1. 1H MRS on Perchloric Acid Extract -- 7.2.3.2. 31P MRS on Perchloric Acid Extracts -- 7.2.3.3. 31P MRS on Chloroform-Methanol Extracts -- 7.2.3.4. 1H MRS Based on Dual Extraction Technique -- 7.3. Ex Vivo MRS of Breast Tumors -- 7.3.1. Sample Preparation -- 7.3.2. MRS Method -- 7.3.3. Results -- 7.4. HRMAS Spectroscopy of Breast Tumors -- 7.4.1. Sample Preparation -- 7.4.2. MRS Method -- 7.4.3. Results -- 7.5. Summary -- References -- Future Directions -- References -- Index.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

© 2024 Resource Centre. All rights reserved.